Indian generic drug firms court US off-patent market

With $32 billion worth of drugs going off patent in the next two years, Indian pharma companies are going all out to launch generics in the US market

http://www.financialexpress.com/archive/indian-generic-drug-firms-court-us-off-patent-market/1235569/